Exclusive: Healthcare Service Provider Scorpius Surpasses $100M In Business Opportunities, Eyes Revenue Boost

Scorpius Holdings, Inc. SCPX announced that it has surpassed $100 million in near-term business development opportunities across government and commercial sectors.

The Company expects these opportunities to translate into substantial booked business and associated revenues over the next two quarters.

Also Read: EXCLUSIVE: Healthcare Service Provider Scorpius Projects Over 375% Sequential Increase In Q4 Revenue

Key opportunities include:

• Several new commercial customers within the current quarter
• Multiple repeat client booking opportunities that will carry over into 2025, representing an anticipated $15 million in additional bookings
• Multiple opportunities for expanded scope of work with existing clients, including
  • A single project that could consume a majority of Scorpius' microbial production capacity and trigger capacity expansion activities in the Company's 2025 microbial production suites
  • Anticipated substantial project expansion with one of the nation's leading universities
• Government proposals submitted to fund an additional Bio Safety Level 3 capable facility along with several innovative monoclonal antibody development (mAb) programs

Jeff Wolf, CEO of Scorpius Holdings, commented, "We expect to close on many of these opportunities before the year's end, which will not only generate substantial revenue this year and next but also contribute significantly to our cash flow."

Price Action: SCPX shares closed lower by 8.09% at $4.72 Monday.